Apr 5 |
Chief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)
|
Apr 5 |
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
|
Mar 25 |
Chief Development Officer Darlene Noci Sells 20,000 Shares of Nuvalent Inc (NUVL)
|
Mar 22 |
Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth
|
Mar 5 |
Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024
|
Feb 29 |
Nuvalent Inc (NUVL) Reports Full Year and Q4 2023 Financial Results with Strong Cash Position ...
|
Feb 27 |
Nuvalent lung cancer candidate gets FDA breakthrough therapy status
|
Feb 27 |
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 27 |
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520
|
Feb 26 |
Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024
|